We serve Chemical Name:1,12-dicarba-closo-dodecaborane(12) CAS:20644-12-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:1,12-dicarba-closo-dodecaborane(12)
CAS.NO:20644-12-6
Synonyms:1,7-dicarba-closo-dodecaborane;1,12-bis[4-(bromomethyl)phenoxy]dodecane;1,12-dicarba-closo-dodecarborane;para-dicarbadodecaborane
Molecular Formula:C2B10
Molecular Weight:132.13100
HS Code:
Physical and Chemical Properties:
Melting point:200-203ºC(lit.)
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:
Exact Mass:134.09300
LogP:
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 1,7-dicarba-closo-dodecaborane chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,para-dicarbadodecaborane physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1,7-dicarba-closo-dodecaborane Use and application,1,12-bis[4-(bromomethyl)phenoxy]dodecane technical grade,usp/ep/jp grade.
Related News: The FDA also said that the labeling of the diagnostic, which comes in different versions, included performance claims that did not match up with results seen in clinical studies—and that the data Innova submitted for review “was identical to data previously provided by other manufacturers” in separate requests for emergency COVID authorizations, raising additional questions. 1,12-dicarba-closo-dodecaborane(12) manufacturer Further research on Oligomannate��s pharmacological mechanism and long-term safety and effectiveness is required, according to the NMPA statement. 1,12-dicarba-closo-dodecaborane(12) supplier Domestic API companies cooperate with major international companies through commissioned processing, patent transfer, and joint venture production. 1,12-dicarba-closo-dodecaborane(12) vendor It is understood that at present, the industry competition for global characteristic APIs has shown a development trend of vertical integration, and the number of mergers and acquisitions between pharmaceutical manufacturers and API manufacturers is increasing. 1,12-dicarba-closo-dodecaborane(12) factory Domestic API companies cooperate with major international companies through commissioned processing, patent transfer, and joint venture production.
